Michael J Dickinson (Michael Dickinson, M Dickinson)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 51

Top Topics

Newly Diagnosed

Hodgkin Lymphoma

Stem Cell Transplantation

Prognostic Factors

Top Venues

Internal medicine journal

The New England journal of medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Cameron S Lewis, Greta Joy, Paw Jensen, Allison Barraclough, Nunzio Franco, Dipti Talaulikar, Eliza A Hawkes, Tarec Christoffer El-Galaly, Diego R Villa, Michael J Dickinson, John Francis Seymour, Chan Yoon Y Cheah
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study. British journal of haematology (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Martin Dreyling, Nathan H Fowler, Michael J Dickinson, Joaquín Martínez-López, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Babis Andreadis, Peter A Riedell, P Joy Ho, Jose Antonio Perez-Simon, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh Stephen O'Donovan, Roberto Javier Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update. Blood (2024)
Martin Dreyling, Nathan H Fowler, Michael J Dickinson, Joaquín Martínez-López, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Babis Andreadis, Peter A Riedell, P Joy Ho, Jose Antonio Perez-Simon, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh Stephen O'Donovan, Roberto Javier Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable Response After Tisagenlecleucel in Adults With Relapsed/Refractory Follicular Lymphoma: ELARA Trial Update. Blood (2024)
Valeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld, Carmela Sales, Samantha van der Linde, Izanne Roos, Stefanie Roberts, Fiore D'Aprano, Samantha M Loi Franzcp PhD Mbbs, Mark R Dowling, Michael J Dickinson, Tomas Kalincik, Simon James Harrison, Mary Ann Anderson, Charles B Malpas
Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective study. BMJ neurology open 6 (2) (2024)
Michael Sargent Binkley, Jamie E Flerlage, Kerry Joane Savage, Saad Akhtar, Raphael E Steiner, Xiao-Yin Zhang, Michael J Dickinson, Anca Prica, Ajay Major, Peter G Hendrickson, David Hopkins, Andrea K Ng, Carla Casulo, Jonathan Baron, Kenneth B Roberts, Jalila Alkendi, Alex Balogh, Umberto Ricardi, Pallawi Torka, Lena Specht, Ravindu De Silva, Keir Pickard, Lindsay J Blazin, Michael Henry, Christine Moore Smith, Daniel Halperin, Jessica Brady, Bernadette Brennan, Maria Anatolevna Senchenko, Marie Reeves, Bradford S Hoppe, Stephanie A Terezakis, Dipti Talaulikar, Marco Picardi, Youlia Kirova, Paige Fergusson, Eliza A Hawkes, Denise Lee, Nicole Wong Doo, Allison Barraclough, Chan Yoon Y Cheah, Matthew Ku, Nada Hamad, Howard Mutsando, Michael Gilbertson, Tamara Marconi, Nicholas Viiala, Matthew John Maurer, Dennis A Eichenauer, Richard T Hoppe, null null
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Michael Sargent Binkley, Jamie E Flerlage, Kerry Joane Savage, Saad Akhtar, Raphael E Steiner, Xiao-Yin Zhang, Michael J Dickinson, Anca Prica, Ajay Major, Peter G Hendrickson, David Hopkins, Andrea K Ng, Carla Casulo, Jonathan Baron, Kenneth B Roberts, Jalila Alkendi, Alex Balogh, Umberto Ricardi, Pallawi Torka, Lena Specht, Ravindu De Silva, Keir Pickard, Lindsay J Blazin, Michael Henry, Christine Moore Smith, Daniel Halperin, Jessica Brady, Bernadette Brennan, Maria Anatolevna Senchenko, Marie Reeves, Bradford S Hoppe, Stephanie A Terezakis, Dipti Talaulikar, Marco Picardi, Youlia Kirova, Paige Fergusson, Eliza A Hawkes, Denise Lee, Nicole Wong Doo, Allison Barraclough, Chan Yoon Y Cheah, Matthew Ku, Nada Hamad, Howard Mutsando, Michael Gilbertson, Tamara Marconi, Nicholas Viiala, Matthew John Maurer, Dennis A Eichenauer, Richard T Hoppe, null null
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Michael Sargent Binkley, Jamie E Flerlage, Kerry Joane Savage, Saad Akhtar, Raphael E Steiner, Xiao-Yin Zhang, Michael J Dickinson, Anca Prica, Ajay Major, Peter G Hendrickson, David Hopkins, Andrea K Ng, Carla Casulo, Jonathan Baron, Kenneth B Roberts, Jalila Alkendi, Alex Balogh, Umberto Ricardi, Pallawi Torka, Lena Specht, Ravindu De Silva, Keir Pickard, Lindsay J Blazin, Michael Henry, Christine Moore Smith, Daniel Halperin, Jessica Brady, Bernadette Brennan, Maria Anatolevna Senchenko, Marie Reeves, Bradford S Hoppe, Stephanie A Terezakis, Dipti Talaulikar, Marco Picardi, Youlia Kirova, Paige Fergusson, Eliza A Hawkes, Denise Lee, Nicole Wong Doo, Allison Barraclough, Chan Yoon Y Cheah, Matthew Ku, Nada Hamad, Howard Mutsando, Michael Gilbertson, Tamara Marconi, Nicholas Viiala, Matthew John Maurer, Dennis A Eichenauer, Richard T Hoppe, null null
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Cameron S Lewis, Greta Joy, Paw Jensen, Allison Barraclough, Nunzio Franco, Dipti Talaulikar, Eliza A Hawkes, Tarec Christoffer El-Galaly, Diego R Villa, Michael J Dickinson, John Francis Seymour, Chan Yoon Y Cheah
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study. British journal of haematology 205 (2) (2024)
Adrian G Minson, Nada Hamad, Chan Yoon Y Cheah, Constantine S Tam, Piers Blombery, David A Westerman, David S Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John Francis Seymour, Molly Robertson, Imogen Caldwell, Georgina L Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel M Koldej, Michael J Dickinson
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study. Blood (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)
Michael J Dickinson, Pere Barba, Ulrich Jäger, Nirav N Shah, Didier Blaise, Javier Briones, Leyla Shune, Nicolas Boissel, Attilio Bondanza, Luisa Mariconti, Anne-Laure Marchal, David S Quinn, Jennifer Yang, Andrew Price, Akash Sohoni, Louise M Treanor, Elena J Orlando, Jennifer Mataraza, Jaclyn Davis, Darlene Lu, Xu Zhu, Boris Engels, Laure Moutouh-de Parseval, Jennifer L Brogdon, Michele Moschetta, Ian W Flinn
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-Cell Stemness Shows Enhanced CAR T-Cell Efficacy in Preclinical and Early Clinical Development. Cancer discovery (2023)
Jason R Westin, Olalekan O Oluwole, Marie José Kersten, David B Miklos, Miguel-Angel Perales, Armin Ghobadi, Aaron P Rapoport, Anna Sureda, Caron A Jacobson, Umar Farooq, Tom van Meerten, Matthew Ulrickson, Mahmoud Elsawy, Lori A Leslie, Sridhar Chaganti, Michael J Dickinson, Kathleen Dorritie, Patrick M Reagan, Joseph McGuirk, Kevin W Song, Peter A Riedell, Monique C Minnema, Yin Yang, Saran Vardhanabhuti, Simone Filosto, Paul Cheng, Shilpa A Shahani, Marco Schupp, Christina To, Frederick L Locke, null null
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. The New England journal of medicine (2023)
Matthew James Rees, Michael J Dickinson, James Paterson, Teng F Ng, Andrew Grigg, John Moore, Piers Blombery, John F Seymour
Targeting the BRAF pathway in haematological diseases. Internal medicine journal 53 (5) (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)
Thomas E Lew, Edward Robert Scheffer Cliff, Michael J Dickinson, Constantine S Tam, John Francis Seymour, Piers A Blombery, Ashish Bajel, David S Ritchie, Amit Khot
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease. Leukemia & lymphoma (2023)
Jason R Westin, Frederick L Locke, Michael J Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David Bernard Miklos, Matthew L Ulrickson, Miguel-Ángel Perales, Umar Farooq, Luciano Wannesson, Lori A Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Georg Wulf, Patrick B Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O Oluwole, Anna Sureda
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine (2022)
James Nguyen, Cameron Wellard, Eliza Chung, Chan Yoon Y Cheah, Michael J Dickinson, Nicole Wong Doo, Colm Keane, Dipti Talaulikar, Leanne Berkahn, Susan Morgan, Nada Hamad, Tara Cochrane, Anna M Johnston, Cecily Forsyth, Stephen Opat, Allison Barraclough, Howard Mutsando, Sumita Ratnasingam, Pratyush Giri, Erica Michelle Wood, Zoe K McQuilten, Eliza A Hawkes, null null
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European journal of haematology 110 (4) (2022)
Mark A Dawson, Gautam Borthakur, Brian James Patrick Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T Vogl, Daniel A Pollyea, Faith E Davies, Gareth J Morgan, Jacob Lowell Glass, Manali Kamdar, Maria-Victoria Mateos-Manteca, Natalia Tovar, Paul Yeh, Regina García Delgado, Faisal Basheer, Ludovica Marando, Paolo Gallipoli, Anastasia Wyce, Anu Shilpa Krishnatry, Olena Barbash, Evi Bakirtzi, Geraldine Ferron-Brady, Natalie O Karpinich, Michael T McCabe, Shawn W Foley, Thierry Horner, Arindam Dhar, Brandon E Kremer, Michael J Dickinson
A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Adam H Lapidus, Mary Ann Anderson, Simon James Harrison, Michael J Dickinson, Tomas Kalincik, Arian Lasocki
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leukemia & lymphoma 63 (10) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Ann-Marie E Bröske, Koorosh Korfi, Anton Belousov, Sabine Wilson, Chia-Huey Ooi, Christopher R Bolen, Marta Canamero, Enrique Gomez Alcaide, Ian James, Emily C Piccione, David J Carlile, Natalie Dimier, Pablo Umaña, Marina Bacac, Martin Weisser, Michael J Dickinson
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma. Blood advances 6 (3) (2022)
James Nguyen, Cameron Wellard, Eliza Chung, Chan Yoon Y Cheah, Michael J Dickinson, Nicole Wong Doo, Colm Keane, Dipti Talaulikar, Leanne Berkahn, Susan Morgan, Nada Hamad, Tara Cochrane, Anna M Johnston, Cecily Forsyth, Stephen Opat, Allison Barraclough, Howard Mutsando, Sumita Ratnasingam, Pratyush Giri, Erica Michelle Wood, Zoe K McQuilten, Eliza A Hawkes, null null
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European journal of haematology 110 (4) (2022)
James Nguyen, Cameron Wellard, Eliza Chung, Chan Yoon Y Cheah, Michael J Dickinson, Nicole Wong Doo, Colm Keane, Dipti Talaulikar, Leanne Berkahn, Susan Morgan, Nada Hamad, Tara Cochrane, Anna M Johnston, Cecily Forsyth, Stephen Opat, Allison Barraclough, Howard Mutsando, Sumita Ratnasingam, Pratyush Giri, Erica Michelle Wood, Zoe K McQuilten, Eliza A Hawkes, null null
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European journal of haematology (2022)
Constantine S Tam, P J Ho, Duncan Purtill, Emily Blyth, Jason Butler, Michael J Dickinson, Simon Harrison
Fitness criteria for Australian patients referred for chimeric antigen receptor T-cell therapy. Internal medicine journal 52 (8) (2022)
James Nguyen, Cameron Wellard, Eliza Chung, Chan Yoon Y Cheah, Michael J Dickinson, Nicole Wong Doo, Colm Keane, Dipti Talaulikar, Leanne Berkahn, Susan Morgan, Nada Hamad, Tara Cochrane, Anna M Johnston, Cecily Forsyth, Stephen Opat, Allison Barraclough, Howard Mutsando, Sumita Ratnasingam, Pratyush Giri, Erica Michelle Wood, Zoe K McQuilten, Eliza A Hawkes, null null
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. European journal of haematology 110 (4) (2022)
Gilles Andre Salles, Stephen J Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Piers E M Patten, Bastian von Tresckow, Sonali M Smith, Ana Jiménez-Ubieto, Keith L Davis, Carla Anjos, Jufen Chu, Jie Zhang, Chiara Lobetti Bodoni, Catherine Thieblemont, Nathan H Fowler, Michael J Dickinson, Joaquin Martínez-López, Yucai Wang, Brian L Link
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma. Blood advances 6 (22) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Michael J Dickinson, Carmello Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine 387 (24) (2022)
Sattva S Neelapu, Michael J Dickinson, Javier Munoz, Matthew L Ulrickson, Catherine Thieblemont, Olalekan O Oluwole, Alex F Herrera, Chaitra S Ujjani, Yi Lin, Peter A Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C Chavez
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial. Nature medicine 28 (4) (2022)
Adrian G Minson, Michael S Hofman, Michael J Dickinson
A PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse. Leukemia & lymphoma 63 (1) (2021)
Pier Luigi Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, José S R Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael J Dickinson, Andrew Bruce McDonald, Muhit Özcan, Naohiro Sekiguchi, Ying Zhu, Monika Raut, Todd L Saretsky, Akash Nahar, John George Kuruvilla
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. Blood advances (2021)
Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmello Carlo-Stella, Fritz C Offner, Anna Sureda, Gilles Andre Salles, Joaquín Martínez-Lopez, Michael Crump, Denise N Thomas, Peter N Morcos, Cristiano Ferlini, Ann-Marie E Bröske, Anton Belousov, Marina Bacac, Natalie Dimier, David J Carlile, Linda Lundberg, David Perez-Callejo, Pablo Umaña, Tom Moore, Martin Weisser, Michael J Dickinson
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Joel C Wight, Nada Hamad, B A Campbell, Matthew Ku, K Lee, H Rose, T Armytage, M Latimer, H P Lee, Sze Ting Lee, Michael J Dickinson, R Khor, E Verner
Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma Alliance. Internal medicine journal (2021)
Georgia J McCaughan, Pietro R Di Ciaccio, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, Benjamin Teh, Robert Weinkove, Jennifer Curnow, Jeffrey Szer, Anoop K Enjeti, David M Ross, Stephen Mulligan, Judith Trotman, Michael J Dickinson, Hang Quach, Philip Young-Ill Choi, Mark N Polizzotto, Constantine S Tam, P Joy Ho, Matthew Ku, Gareth Gregory, Shane Gangatharan, Gregory Hapgood, Tara Cochrane, Chan Cheah, Simon Gibbs, Andrew Wei, Anna Johnston, Matthew Greenwood, H Miles Prince, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Nada Hamad
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement. Internal medicine journal 51 (5) (2021)
Tara Cochrane, Belinda A Campbell, Shane A Gangatharan, Maya Latimer, Richard Khor, David R H Christie, Michael Gilbertson, Sumita Ratnasingam, Emma Palfreyman, Hui-Peng Lee, Judith Trotman, Mark Hertzberg, Michael J Dickinson
Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal medicine journal (2021)
Michael J Dickinson, Javier Briones, Alex F Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma. Blood advances 5 (22) (2021)
Pietro R Di Ciaccio, Georgia McCaughan, Judith Trotman, Phoebe Joy Ho, Chan Yoon Y Cheah, Shane Gangatharan, Joel Wight, Matthew Ku, Hang Quach, Robin Gasiorowski, Mark N Polizzotto, Henry Miles Prince, Stephen Mulligan, Constantine S Tam, Gareth Gregory, Gregory Hapgood, Andrew Spencer, Michael J Dickinson, Maya Latimer, Anna Johnston, Tasman Armytage, Cindy Lee, Tara Cochrane, Leanne Berkhahn, Robert Weinkove, Richard Doocey, Simon J Harrison, Nicholas Webber, Hui-Peng Lee, Scott Chapman, Belinda A Campbell, Simon D J Gibbs, Nada Hamad
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Internal medicine journal 50 (6) (2020)
Michael J Dickinson, Robert Weinkove
Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies. Internal medicine journal 49 (10) (2019)
Michael J Dickinson, Honar Cherif, Pierre Fenaux, Moshe Mittelman, Amit Verma, Maria Socorro O Portella, Paul Burgess, Pedro Marques Ramos, Jeea Choi, Uwe Platzbecker, null null
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia. Blood 132 (25) (2018)